bispecific antibody Archives -

Roche will present the new data at next week’s ASCO congress showing that its bispecific antibody glofitamab can

Roche trumpets new glofitamab data in lymphoma at ASCO

https://pharmaphorum.com/news/roche-trumpets-new-glofitamab-data-in-lymphoma-at-asco/

Affimed says new data from a phase 1/2 trial of its natural killer (NK) cell engager therapy AFM13

AACR: Affimed builds case for natural killer cell therapy

https://pharmaphorum.com/news/aacr-affimed-builds-case-for-natural-killer-cell-therapy/

Sanofi has joined a growing list of drugmakers going after alpha-synuclein targeting drugs for Parkinson’s disease, licensing a

Sanofi places $75m bet with ABL on popular Parkinson’s drug target

https://pharmaphorum.com/news/sanofi-places-75m-bet-with-abl-on-popular-parkinsons-drug-target/

Fresh from claiming its first bispecific antibody approval, Johnson & Johnson has delved deeper into the category with

J&J bulks up in bispecifics with $1.3bn Xencor alliance

https://pharmaphorum.com/news/jj-bulks-up-in-bispecifics-with-1-3bn-xencor-alliance/

With the ink barely dry on the FDA’s approval of Johnson & Johnson’s Rybrevant, its first bispecific antibody

Straight after its first cancer bispecific OK, J&J highlights two more at ASCO

https://pharmaphorum.com/news/straight-after-its-first-cancer-bispecific-ok-jj-highlights-two-more-at-asco/

Always a big player in oncology, Eli Lilly has fallen behind some of its rivals when it comes

Lilly bolts on cancer bispecifics with $1.6bn Merus alliance

https://pharmaphorum.com/news/lilly-bolts-on-cancer-bispecifics-with-1-6bn-merus-alliance/

Genmab has shattered recent records with its Nasdaq listing, raising $506 million to help it advance multiple antibody

Denmark’s Genmab raises a bumper $500m-plus in Nasdaq IPO

https://pharmaphorum.com/news/denmarks-genmab-raises-a-bumper-500m-plus-in-nasdaq-ipo/

Agreement could add to Novartis’ immuno-oncology pipeline.

Novartis buys into bispecific antibodies with Xencor deal

https://pharmaphorum.com/news/novartis-signs-150m-antibody-deal-xencor/

bispecific antibody